Why the study?
Does human urotensin-II cause contraction in human coronary bypass grafts and monkey arteries in vitro?
Does human urotensin-II cause contraction in human coronary bypass grafts and monkey arteries in vitro?
Human urotensin-II elicits variable, low-to-moderate contractile responses in some human arterial bypass grafts but not in saphenous veins, contrasting with strong responses in monkey arteries.
Answers are grounded in this paper and cite their sources.
Cautions against extrapolating primate responses to humans; hypothesis-generating for urotensin-II effects in bypass grafts.
Human urotensin-II (hU-II) is a cyclic peptide recently cloned in humans and present in human cardiac tissue and human arteries. The effects of hU-II were studied on human coronary bypass grafts in vitro. In three out of eight human mammary arteries, and two out of three human radial arteries, hU-II caused contraction; human saphenous veins did not respond to hU-II. When it exists, the contraction slowly develops and has a low-to-moderate intensity. All radial arteries obtained from young healthy non-human primates contracted strongly to hU-II.
No takes yet. Share an insight, caveat, or question.
Paysant et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: